Zervimesine (CT1812) is an orally active and brain penetrant sigma-2 receptor antagonist with a Ki of 8.5 nM. Zervimesine can be used for the research of Alzheimers disease[1].
Molecular Weight:
431.59
Purity:
99.01
CAS Number:
[1802632-22-9]
Formula:
C24H33NO4S
Target:
Sigma Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
